Literature DB >> 33229013

Launching a resiliency group program to assist frontline clinicians in meeting the challenges of the COVID-19 pandemic: Results of a hospital-based systems trial.

Elyse R Park1, Louisa G Sylvia2, Joanna M Streck3, Christina M Luberto4, Amelia M Stanton2, Giselle K Perez3, Margaret Baim5, Cayley C Bliss6, Mary Susan Convery7, Sydney Crute6, John W Denninger8, Karen Donelan9, Michelle L Dossett10, Maurizio Fava2, Stacie Fredriksson11, Gregory Fricchione8, Nevita George12, Daniel L Hall3, Betsy Remington Hart11, John Herman2, April Hirschberg2, Daphne Holt2, Sara E Looby13, Laura Malloy5, Jocelyn Meek5, Darshan H Mehta14, Rachel A Millstein2, Helen Mizrach6, Katherine Rosa5, Ellen Slawsby5, A Clare Stupinski11, Lara Traeger2, Rachel Vanderkruik2, Christine Vogeli9, Sabine Wilhelm2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33229013      PMCID: PMC7605784          DOI: 10.1016/j.genhosppsych.2020.10.005

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


× No keyword cloud information.
COVID-19 has caused an unprecedented healthcare crisis, which has taken a toll on frontline clinicians (FC) [1,2], The MassGeneral Brigham (MGB) hospital system launched an FC resiliency group program and assessed its feasibility, acceptability, and efficacy. Upon IRB approval, English-speaking FCs were recruited (3/23/20–6/02/20) for 17 groups, and completed optional pre and post-treatment surveys. The treatment, previously assessed in caregivers and clinicians, was grounded in relaxation response elicitation, mindfulness, cognitive behavioral therapy, and positive psychology [3,4] and adapted for FCs (health and job uncertainty, clinical role transitions, isolation, and financial and family challenges). Program delivery was modified to eight 1-h biweekly sessions via a HIPAA compliant synchronous videoconferencing platform. Groups were co-facilitated by MGB staff trained in the Stress Management and Resiliency Training-Relaxation Response Program (SMART-3RP) delivery, offered at flexible times, and organized according to FC specialty. Group facilitators attended biweekly clinical supervision, documented attendance, and completed treatment fidelity checklists. No serious adverse events were reported. Demographics and work characteristics, feasibility (attendance at 6 out of the 8 sessions) and acceptability (program met needs, helpfulness) were assessed. Primary outcomes were assessed by 1–2 items of validated scales: stress reactivity [5], perceived stress coping (0–10 analog), distress [6], and resiliency [7]; and secondary outcomes: loneliness/isolation [8], self-compassion [9], and mindfulness [10]. Descriptive statistics, paired sample t-tests, and Cohen's D were calculated (Stata version 16). Content analyses were conducted (NVivo 12) by 2 independent coders (kappa = 0.92). 147 FCs registered, and 102 (69%) completed a baseline assessment. Participants were 92.1% female, 83.3% White, non-Hispanic, 8.8% Asian, 3.9% Black, 9.8% Hispanic and 2% Other. A variety of clinical specialties were represented with the largest groups: Social Workers/Chaplains/Psychologists (24.5%), Respiratory/Physical/Speech Therapists (18.6%), nurses (17.7%), nurse practitioners and physician assistants (15.7%), and physicians (12.8%). 34.3% of participants reported an increase in work hours in the past month, 81.4% reported a change in work setting, and 49.0% reported a change in clinical role. One hundred FCs attended at least one session, and 75% of participants completed both a baseline and end of treatment assessment. Participants completed a mean of 6 sessions; 64% completed >6 sessions. 96% of participants agreed that the program met their needs, and 99% agreed that the program was helpful. Participants' open ended responses revealed that the program structure and sharing with others facing similar workplace-challenges were the most helpful aspects of the group. Positive reappraisal and enhancing social support and connectedness were the skills reported as the most helpful. All outcomes significantly improved (ps < 0.01) (Table 1 ) with medium to large effects for all primary outcomes.
Table 1

Pre/post treatment outcomes (n = 75).

Pre M (SD)Post M (SD)p-valueCohen's D
Primary Outcomes (Score Range)
 Stress Coping (analog; 0–10)6.5 (1.5)7.4 (1.1)<0.010.66
Stress Coping Personal Strengths (MOCS-A; 1–5)
 Coping Response3.3 (0.8)4.0 (0.7)<0.010.80
 Emotionally Balanced Thoughts3.5 (0.7)3.9 (0.7)<0.010.50
 Resiliency (CES; 0–10)6.3 (1.4)7.1 (1.5)<0.010.56
 Emotional Distress (PHQ-4; 0–12)3.9 (2.7)2.3 (1.9)<0.010.64
Secondary Outcomes
 Loneliness/Isolation (UCLA; 2–8)3.1 (1.1)2.7 (0.9)<0.010.44
 Mindfulness (CAMS-R; 2–8)5.5 (1.2)6.1 (1.1)<0.010.55
 Self-Compassion (SCS; 1–5)3.7 (0.9)3.3 (1.0)<0.010.35
Pre/post treatment outcomes (n = 75). An FC adapted resiliency group program was successfully implemented, across a large hospital system, and decreased COVID-19-associated distress and improved resiliency. Providers were engaged during a public health crisis. Limitations included self-reported outcomes and limited gender diversity. Preserving FC resiliency is of upmost importance during the pandemic and can be achieved through a targeted, accessible group-based treatment.

Funding support

None. We would like to express our gratitude for our team who volunteered their time, at the onset of the pandemic, to assist frontline clinicians.
  6 in total

1.  Supporting the Health Care Workforce During the COVID-19 Global Epidemic.

Authors:  James G Adams; Ron M Walls
Journal:  JAMA       Date:  2020-04-21       Impact factor: 56.272

2.  An ultra-brief screening scale for anxiety and depression: the PHQ-4.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams; Bernd Löwe
Journal:  Psychosomatics       Date:  2009 Nov-Dec       Impact factor: 2.386

3.  Developing a measure of loneliness.

Authors:  D Russell; L A Peplau; M L Ferguson
Journal:  J Pers Assess       Date:  1978-06

4.  A Virtual Resiliency Intervention Promoting Resiliency for Parents of Children with Learning and Attentional Disabilities: A Randomized Pilot Trial.

Authors:  Elyse R Park; Giselle K Perez; Rachel A Millstein; Christina M Luberto; Lara Traeger; Jacqueline Proszynski; Emma Chad-Friedman; Karen A Kuhlthau
Journal:  Matern Child Health J       Date:  2020-01

5.  Building Resiliency in a Palliative Care Team: A Pilot Study.

Authors:  Darshan H Mehta; Giselle K Perez; Lara Traeger; Elyse R Park; Roberta E Goldman; Vivian Haime; Eva H Chittenden; John W Denninger; Vicki A Jackson
Journal:  J Pain Symptom Manage       Date:  2015-11-06       Impact factor: 3.612

6.  Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis.

Authors:  Sofia Pappa; Vasiliki Ntella; Timoleon Giannakas; Vassilis G Giannakoulis; Eleni Papoutsi; Paraskevi Katsaounou
Journal:  Brain Behav Immun       Date:  2020-05-08       Impact factor: 7.217

  6 in total
  4 in total

Review 1.  Systematic Review of Mind-Body Modalities to Manage the Mental Health of Healthcare Workers during the COVID-19 Era.

Authors:  Chan-Young Kwon; Boram Lee
Journal:  Healthcare (Basel)       Date:  2022-06-01

2.  Mental and physical exhaustion of health-care practitioners.

Authors:  Richard F Mollica; Gregory L Fricchione
Journal:  Lancet       Date:  2021-12-18       Impact factor: 79.321

3.  Randomized Waitlist-Control Trial of a Web-Based Stress-Management and Resiliency Program for Adolescent and Young Adult Cancer Survivors: Protocol for the Bounce Back Study.

Authors:  Helen Mizrach; Brett Goshe; Elyse R Park; Christopher Recklitis; Joseph A Greer; Yuchiao Chang; Natasha Frederick; Annah Abrams; Mary D Tower; Emily A Walsh; Mary Huang; Lisa Kenney; Alan Homans; Karen Miller; John Denninger; Ghazala Naheed Usmani; Jeffrey Peppercorn; Giselle K Perez
Journal:  JMIR Res Protoc       Date:  2022-01-26

4.  Moderators of a resiliency group intervention for frontline clinicians during the COVID-19 pandemic.

Authors:  Louisa G Sylvia; Nevita George; Dustin J Rabideau; Joanna M Streck; Evan Albury; Daniel L Hall; Christina M Luberto; Helen R Mizrach; Giselle K Perez; Sydney Crute; Darshan H Mehta; Mary Susan Convery; Sara E Looby; Gregory Fricchione; Maurizio Fava; Sabine Wilhelm; Elyse R Park
Journal:  J Affect Disord       Date:  2021-06-24       Impact factor: 4.839

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.